Dr. Josh Sharan is a distinguished physician-scientist with deep expertise in drug development and therapeutic venture capital. As the Chief Scientific Officer at Camelot BioCapital, Dr. Sharan leads the identification and evaluation of promising therapeutic candidates, overseeing technical diligence and acquisition efforts to drive innovation in the biotech landscape.
Dr. Sharan is also a co-founder of TMAB Therapeutics and Emerald Biotherapeutics, where he provides strategic and operational support to portfolio companies.
Dr. Sharan has a Doctor of Osteopathic Medicine degree from Nova Southeastern University. He has professional affiliations with the American Society of Gene & Cell Therapy and The Antibody Society.
